Author

Shinji Nakamichi

National Institutes of HealthORCID 0000-0002-2298-6945Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Curtis C. HarrisiD· 1 shared Drew WeissmaniD· 1 shared Hamideh ParhiziD· 1 shared Izumi HorikawaiD· 1 shared Jilian R. MelamediD· 1 shared Leo YamadaiD· 1 shared Natalia von MuhlineniD· 1 shared Tyler Ellis PappiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Curtis C. HarrisORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancer

Shinji Nakamichi, Natalia von Muhlinen, Leo Yamada, Jilian R. Melamed, Tyler Ellis Papp, Hamideh Parhiz, Drew Weissman, Izumi Horikawa, Curtis C. Harris

This study shows that knocking down SRSF3 induces cellular senescence in NSCLC cells, including those without targetable mutations, suggesting a potential new therapeutic strategy.

Carcinogenesis · Oct 1, 2025Peer-reviewedCancer Biology